Cerner Collaborates With Geisinger, xG Health Solutions to Enable SMART on FHIR EHR Apps

KANSAS CITY, Mo., April 14, 2015 (GLOBE NEWSWIRE) -- Cerner Corp., Geisinger Health System and xG Health Solutions have collaborated to enable the use of emerging SMART(R) on FHIR(R) industry standards to facilitate use of software applications across compliant "open platform" electronic health record (EHR) systems, such as Cerner Millennium(R).

Geisinger and xG Health will be able to use these new draft standards to deploy their innovative apps to run inside Cerner Millennium and other FHIR-compliant EHR systems. The SMART-on-FHIR approach enables clinicians to access these "pluggable apps" directly within their workflows. Cerner developers have enabled seamless integration of the xG Health apps into the Cerner Millennium open platform as a way to eliminate disjointed workflows of standalone or "sidecar" applications.

xG Health will demonstrate the new technology in Cerner's booth (913) at HIMSS15. Dr. Alistair Erskine, chief clinical informatics officer of Geisinger, will participate in Cerner's Media Breakfast at HIMSS on April 14.

"SMART on FHIR creates an important new kind of interoperability," said Dr. David McCallie, Jr., senior vice president, medical informatics at Cerner. "Application interoperability will enable innovative developers to reach a broader market of potential users, while at the same time enabling open platform EHR suppliers to provide a more robust set of offerings to their clients."

Cerner, xG Health and Geisinger's first initiative under the agreement, first piloted within Cerner Millennium in October 2014, is a Geisinger-developed, web-based application for managing ambulatory rheumatology encounters. The EnrG | Rheum(TM) app - the first of a suite of xG Health EnrG apps - synthesizes information from multiple sources regarding an individual patient and presents it in a clinically useful graphical view along with clinical decision support that helps to increase quality and reduce cost of care. Clinicians at two sites saw a 26 percent increase in productivity, due to a decrease in chart review and documentation time, while using the EnrG | Rheum software over a two-year period.

"Cerner's leadership role in supporting and implementing the draft SMART on FHIR standard has made them a great partner to work with and to help make Geisinger-vetted care models available to Cerner customers," said Earl Steinberg, MD, MPP, CEO of xG Health. "As the industry advances toward improved and robust interoperability capabilities, this type of collaboration can help transform the way care is delivered."

This summer, xG Health is expected to launch EnrG | Rheum, which will be available through the Cerner Store and other channels.

 

About Cerner

Cerner's health information technologies connect people, information and systems at more than 18,000 facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients' clinical, financial and operational needs.

Cerner's mission is to contribute to the improvement of health care delivery and the health of communities. On February 2, 2015, Cerner Corporation acquired substantially all of the assets, and assumed certain liabilities, of the Siemens Health Services business from Siemens AG. (Nasdaq:CERN). For more information about Cerner, visit cerner.com, read our blog at cerner.com/blog, connect with us on Twitter at twitter.com/cerner and on Facebook at facebook.com/cerner.

Certain trademarks, service marks and logos set forth herein are property of Cerner Corporation and/or its subsidiaries. All other non-Cerner marks are the property of their respective owners.

 

About xG Health Solutions

xG Health helps providers redesign care delivery processes to make them more effective and efficient and provides products and services that help care delivery systems deliver higher quality and lower cost care.

Our products and services, which are powered by Geisinger Health System's proven methods, are of value to providers and payers under fee-for-service, as well as performance- and risk-based payment approaches. For more information, visit www.xghealth.com, LinkedIn or Twitter.

 

About Geisinger

Geisinger Health System is an integrated health services organization widely recognized for its innovative use of the electronic health record, and the development of innovative care models such as ProvenHealth Navigator(R) and ProvenCare(R). As one of the nation(1)s largest rural health services organizations, Geisinger serves more than

3 million residents throughout 48 counties in central, south-central and northeast Pennsylvania. The physician-led system is comprised of approximately 23,500 employees, including a 1,200-member multi-specialty group practice, nine hospital campuses, two research centers and a 467,000-member health plan, all of which leverage an estimated $7.7 billion positive impact on the Pennsylvania economy. The health system and the health plan have repeatedly garnered national accolades for integration, quality and service. In addition to fulfilling its patient care mission, Geisinger has a long-standing commitment to medical education, research and community service. For more information, visit www.geisinger.org, or follow the latest Geisinger news and more on Twitter and Facebook.

 

(c)2015 Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information which may not be reproduced or transmitted without the express written consent of Cerner.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.